ONC
Price:
$331.4
Market Cap:
$41.31B
BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies. Founded in 2010 and headquartered in Cambridge, Massachusetts—with operations spanning over 45 countries across six continents—the company rebranded as BeOne in late 2024 and redomiciled to Basel, Switzerland in 2025. BeOne has established itself as a leader in immuno-oncology and targeted therapies, with key assets including Tevimbra (tislelizumab), a PD-1 monoclonal antibody approved for multiple cancer indications globally, and Brukinsa (zanubrutinib), a Bruton's tyrosine kinase (BTK) inhibitor that surpassed $1.3 billion in annual s...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2016-02-02
Stock Exchange
NASDAQ
Ticker
ONC
According to BeOne Medicines Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 625.28. This represents a change of 247.01% compared to the average of 180.19 of the last 4 quarters.
The mean historical PE Ratio of BeOne Medicines Ltd. over the last ten years is -3.38. The current 625.28 PE Ratio has changed -1847583.46% with respect to the historical average. Over the past ten years (40 quarters), ONC's PE Ratio was at its highest in in the March 2025 quarter at 720.10. The PE Ratio was at its lowest in in the June 2016 quarter at -8.26.
Average
-3.38
Median
-2.13
Minimum
-11.10
Maximum
-0.99
Discovering the peaks and valleys of BeOne Medicines Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 135.34%
Maximum Annual PE Ratio = -0.99
Minimum Annual Increase = -82.64%
Minimum Annual PE Ratio = -11.10
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -3.60 | 54.90% |
| 2023 | -2.32 | 135.34% |
| 2022 | -0.99 | -31.76% |
| 2021 | -1.45 | 14.26% |
| 2020 | -1.27 | -13.43% |
| 2019 | -1.46 | -24.02% |
| 2018 | -1.93 | -82.64% |
| 2017 | -11.10 | 83.81% |
| 2016 | -6.04 | 63.45% |
| 2015 | -3.69 | -66.13% |
The current PE Ratio of BeOne Medicines Ltd. (ONC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.30
5-year avg
-1.93
10-year avg
-3.38
BeOne Medicines Ltd.’s PE Ratio is greater than Humana Inc. (23.63), greater than Insmed Incorporated (-36.68), greater than GE HealthCare Technologies Inc. (16.98), greater than ResMed Inc. (25.62), greater than IQVIA Holdings Inc. (29.84), greater than Alcon Inc. (36.45), greater than Mettler-Toledo International Inc. (35.03), greater than Natera, Inc. (-107.40), greater than Koninklijke Philips N.V. (135.35), greater than Agilent Technologies, Inc. (32.21),
| Company | PE Ratio | Market cap |
|---|---|---|
| 23.63 | $30.43B | |
| -36.68 | $43.73B | |
| 16.98 | $37.69B | |
| 25.62 | $36.86B | |
| 29.84 | $38.30B | |
| 36.45 | $39.07B | |
| 35.03 | $29.07B | |
| -107.40 | $33.41B | |
| 135.35 | $25.35B | |
| 32.21 | $42.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeOne Medicines Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BeOne Medicines Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BeOne Medicines Ltd.'s PE Ratio?
How is the PE Ratio calculated for BeOne Medicines Ltd. (ONC)?
What is the highest PE Ratio for BeOne Medicines Ltd. (ONC)?
What is the 3-year average PE Ratio for BeOne Medicines Ltd. (ONC)?
What is the 5-year average PE Ratio for BeOne Medicines Ltd. (ONC)?
How does the current PE Ratio for BeOne Medicines Ltd. (ONC) compare to its historical average?